Printer Friendly

Implanted glucose monitoring device.

The first FDA-approved, implantable glucose monitoring device, known as the MiniMed Continuous Glucose Sensor system, will soon see regular use at the Diabetes Center at Mercy Medical Center (Baltimore). When the system is in use, a small needle--connected to a tube and inserted into the fatty tissue of the abdomen--measures the glucose level in the tissue every 10 seconds and sends a quantitatively proportionate electronic signal to a monitor to which it is connected. The data is later transferred to a computer and a report is produced showing the patient's glucose level over a given period of time. Thus, clinicians can track glucose levels at 5-minute intervals.
COPYRIGHT 2000 Nelson Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Medical Laboratory Observer
Date:Jun 1, 2000
Words:107
Previous Article:Expedited review for 2 HCV tests.
Next Article:Testing blood for infectious diseases.


Related Articles
Planting seeds for better drug delivery; researchers are attempting to expand the versatility of controlled-release drug implants.
New glucose test on the way for diabetes.
SPECTRX/ABBOTT TO DEVELOP CONTINUOUS GLUCOSE MONITOR.
Artificial pancreas safe, effective in early study.
New diabetes management system receives FDA approval.
FDA grants Medtronic device approvals.
Driving innovation in diabetes care: new diabetes treatment and monitoring technology means opportunity for both patients and medical device...

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |